- Tytuł:
- Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases February 2023 23(2):183-195
Czasopismo naukowe